Carl Gordon

Carl Gordon

Fortuna: 58 170 $ al 31/08/2026

61 años
Health Technology
Finance
Commercial Services

Perfil

Dr. Carl L.
Gordon is an Independent Director at Electra Therapeutics, Inc., a Chairman at Compass Therapeutics, Inc., a Managing Partner at OrbiMed Advisors Private Equity, a Managing Partner at OrbiMed Advisors LLC, an Advisor at The New York City Investment Fund Manager, Inc., an Independent Director at Avenzo Therapeutics, Inc. /New/ and a Principal at Aragon Pharmaceuticals, Inc. He is on the Board of Directors at Lomond Therapeutics Holdings, Inc., Scribe Therapeutics, Inc., Blossomhill Therapeutics, Inc., ADARx Pharmaceuticals, Inc., Electra Therapeutics, Inc., Adimab LLC, Agensys, Inc., Amnis Corp., Emendo Biotherapeutics, Inc., Frontera Therapeutics (HK) Ltd., Gemini Therapeutics Sub, Inc., Gwynant Therapeutics, Inc., Kumquat Biosciences, Inc., Sapphire Therapeutics, Inc., Star OpCo, Inc., Stratus Therapeutics, Inc., X4 Pharmaceuticals (Austria) GmbH, XinThera, Inc. and Avenzo Therapeutics, Inc. /New/.
Dr. Gordon was previously employed as an Independent Director by Arrivent BioPharma, Inc., an Independent Director by MBX Biosciences, Inc., an Independent Director by Keros Therapeutics, Inc., an Independent Director by Kinnate Biopharma, Inc., an Independent Director by Terns Pharmaceuticals, Inc., an Independent Non-Executive Director by Passage Bio, Inc., an Independent Director by Theseus Pharmaceuticals, Inc., an Independent Director by Springworks Therapeutics, Inc., a Lead Independent Director by Turning Point Therapeutics, Inc., an Independent Director by Gemini Therapeutics, Inc., an Independent Director by Oric Pharmaceuticals, Inc., a Chairman by Adicet Bio, Inc., an Independent Director by Intellia Therapeutics, Inc., an Independent Director by Alector, Inc., an Independent Director by Arsanis, Inc., an Independent Director by Selecta Biosciences, Inc., an Independent Director by Complete Genomics, Inc., an Independent Non-Executive Director by Amarin Corp.
Plc, and an Independent Director by Pacira Pharmaceuticals, Inc.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
04/06/2025 5.250 ( 0,03 % ) 58 170 $ 31/08/2026
31/03/2026 0 ( -.--% ) - $ 31/08/2026
06/08/2026 0 ( -.--% ) - $ 31/08/2026

Cargos activos de Carl Gordon

EmpresasCargoInicio
COMPASS THERAPEUTICS, INC. Presidente 01/01/2015
BLOSSOMHILL THERAPEUTICS, INC. Director/Miembro de la Junta 01/02/2021
ELECTRA THERAPEUTICS, INC. Director/Miembro de la Junta 01/03/2019
SCRIBE THERAPEUTICS INC. Director/Miembro de la Junta 01/03/2021
Fundador 01/01/1989
X4 Pharmaceuticals (Austria) GmbH
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░ ░░░░░░ -

Antiguos cargos conocidos de Carl Gordon.

EmpresasCargoFin
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Carl Gordon.

Formación de Carl Gordon.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

62

Relaciones de 1er grado

62

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas62

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Finance

Finance

Finance

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

X4 Pharmaceuticals (Austria) GmbH

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN